...
机译:公爵夫人:对患者患者放射疗法的原位分数对导管癌的评估
Univ Toronto Sunnybrook Hlth Sci Ctr T Wing 2075 Bayview Ave Toronto ON Canada;
McMaster Univ Juravinski Canc Ctr 699 Concess St Hamilton ON Canada;
Univ Toronto Princess Margaret Canc Ctr Toronto ON Canada;
Univ Ottawa Ottawa Hosp Canc Ctr Ottawa ON Canada;
Univ Toronto Sunnybrook Hlth Sci Ctr T Wing 2075 Bayview Ave Toronto ON Canada;
Royal Victoria Reg Hlth Ctr Barrie ON Canada;
Univ Western Ontario London Reg Canc Ctr London ON Canada;
McMaster Univ Juravinski Canc Ctr 699 Concess St Hamilton ON Canada;
Trillium Hlth Partners Mississauga ON Canada;
Thunder Bay Reg Hlth Sci Ctr Thunder Bay ON Canada;
Univ Alberta Cross Canc Inst Edmonton AB Canada;
Univ Calgary Tom Baker Canc Ctr Calgary AB Canada;
McMaster Univ Juravinski Canc Ctr 699 Concess St Hamilton ON Canada;
Univ British Columbia BC Canc Agcy Victoria BC Canada;
McMaster Univ Juravinski Canc Ctr 699 Concess St Hamilton ON Canada;
McMaster Univ Juravinski Canc Ctr 699 Concess St Hamilton ON Canada;
Ductal carcinoma in situ; DCIS; Genomic; Assay; Radiotherapy; De-escalation;
机译:12-基因DCIS评分测定的临床实用性:对导管癌原位患者的放射疗法建议的影响
机译:乳腺辐射脑药学前乳腺癌癌患者预测的同侧肿瘤复发风险的比较乳房辐射手术后乳房辐射手术,Van Nuys预后指数,纪念斯隆kettering癌症中心DCIS invogram,以及12-基因DCIS得分测定
机译:基因组检测对导管癌原位放射治疗建议的影响:12基因DCIS评分结果的前瞻性临床实用性评估
机译:弥散加权成像(DWI)用于挑战性导管原位癌(DCIS)和侵袭性小叶癌(ILC)的乳腺癌
机译:14-3-3 Zeta介导的上皮-间质转化(EMT)有助于ErbB2过表达导管原位癌(DCIS)演变为浸润性乳腺癌
机译:12-基因乳腺DCIS得分®测定与导管癌患者的局部复发原位对促进部分乳房放射治疗方案治疗
机译:DCIs II试验:对患有低风险完全切除的雌激素受体(ER)阳性导管原位癌(DCIs)的妇女进行辅助内分泌治疗的放射治疗的随机试验观察(无放射治疗)。
机译:乳腺导管原位癌(DCIs)的诊断和治疗。证据报告/技术评估编号185